HealthEquity, Inc. (NASDAQ:HQY) Stock Position Lessened by Mackenzie Financial Corp

Mackenzie Financial Corp cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,935,154 shares of the company's stock after selling 422,382 shares during the quarter. Mackenzie Financial Corp owned 2.23% of HealthEquity worth $185,678,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Barclays PLC grew its holdings in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after acquiring an additional 112,667 shares during the period. Assenagon Asset Management S.A. acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $1,452,000. HB Wealth Management LLC acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $261,000. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Finally, Ballentine Partners LLC bought a new position in shares of HealthEquity during the fourth quarter valued at $228,000. Institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HQY. Barrington Research restated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. Royal Bank of Canada assumed coverage on shares of HealthEquity in a research note on Thursday, May 22nd. They issued an "outperform" rating and a $112.00 target price on the stock. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group dropped their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Finally, Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $112.33.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

HealthEquity Stock Performance

HQY traded up $2.13 during trading on Tuesday, reaching $101.14. 804,504 shares of the company's stock were exchanged, compared to its average volume of 807,998. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $8.75 billion, a P/E ratio of 92.79, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company's fifty day simple moving average is $88.65 and its 200-day simple moving average is $97.42. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.